Application of serum neurofilament light chain (sNfL) and glial fibrillary acidic protein (sGFAP) as biomarkers in the clinical management of multiple sclerosis (NeuroFilMS): a protocol for an observational cohort study.
- DOI
- 10.1136/bmjopen-2025-110058
- Published
- 2026 Jul 8
- Container
- BMJ open
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1136/bmjopen-2025-110058,
title = {Application of serum neurofilament light chain (sNfL) and glial fibrillary acidic protein (sGFAP) as biomarkers in the clinical management of multiple sclerosis (NeuroFilMS): a protocol for an observational cohort study.},
author = {Rust R and Samadzadeh S and Röper AL and Stahmann A and Schindler P and Neumaier M and Rausch HW and Schirmer L and Kuhle J and Tumani H and Paul F and Bahr LS},
year = {2026},
journal = {BMJ open},
doi = {10.1136/bmjopen-2025-110058},
url = {https://doi.org/10.1136/bmjopen-2025-110058}
}RIS
TY - JOUR TI - Application of serum neurofilament light chain (sNfL) and glial fibrillary acidic protein (sGFAP) as biomarkers in the clinical management of multiple sclerosis (NeuroFilMS): a protocol for an observational cohort study. AU - Rust R AU - Samadzadeh S AU - Röper AL AU - Stahmann A AU - Schindler P AU - Neumaier M AU - Rausch HW AU - Schirmer L AU - Kuhle J AU - Tumani H AU - Paul F AU - Bahr LS PY - 2026 JO - BMJ open DO - 10.1136/bmjopen-2025-110058 UR - https://doi.org/10.1136/bmjopen-2025-110058 ER -
APA
R, R., S, S., AL, R., A, S., P, S., M, N., HW, R., L, S., J, K., H, T., F, P., & LS, B. (2026). Application of serum neurofilament light chain (sNfL) and glial fibrillary acidic protein (sGFAP) as biomarkers in the clinical management of multiple sclerosis (NeuroFilMS): a protocol for an observational cohort study.. BMJ open. https://doi.org/10.1136/bmjopen-2025-110058
Source records
- pubmed · retrieved 2026-09-25T21:03:40.867Z